Maravai LifeSciences Holdings, Inc. Class A Common Stock (MRVI)
NASDAQ
7.43
-0.42 (-5.35%)
Closed
Oct 7, 2026
Day's Range
7.227.73
52 wk Range
2.549.42
Financial Statements - MRVI - Maravai LifeSciences Holdings, Inc. Class A Common Stock
Revenue
185.74M▼ 28.3%
Net Income
-230.76M▲ 11.1%Net Margin -124.2%
EBITDA
-60.77M▼ 760.3%
Free Cash Flow
-70.72M▼ 198.5%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 185.74M | 259.18M | 288.94M | 883M | 799.24M | 284.09M |
| Cost of Goods | 151.75M | 150.87M | 148.74M | 168.95M | 140.56M | 79.64M |
| Gross Profit | 33.99M | 108.30M | 140.20M | 714.04M | 658.67M | 204.44M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -128.53M | -72.68M | -28.46M | 566.41M | 543.39M | 100.90M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | -90.88M | -168.50M | 664.36M | 3.13M | 17.62M | 11.53M |
| Pre Tax Income | -234.97M | -261.48M | 617.73M | 551.47M | 530.76M | 81.69M |
| Income Tax | -4.21M | -1.86M | 756.11M | 60.80M | 61.51M | 2.88M |
| Net Income | -230.76M | -259.62M | -138.37M | 490.66M | 469.25M | 78.81M |
| EPS Basic | -0.9 | -1.05 | -0.9 | 1.67 | 1.59 | 7.43 |
| EPS Diluted | -0.9 | -1.05 | -0.9 | 1.67 | 1.56 | 2.36 |
| Basic Shares Outstanding | 144.36M | 137.90M | 131.91M | 131.54M | 114.79M | 10.35M |
| Diluted Shares Outstanding | 144.36M | 137.90M | 131.91M | 131.54M | 114.79M | 10.35M |
| Ebit | -207.98M | -213.78M | 663.62M | 571.88M | 561.02M | 112.43M |
| Ebitda | -60.77M | 9.20M | 715.58M | 602.39M | 583.32M | 126.86M |
| Net Income Continuous Operations | -230.76M | -259.62M | -138.37M | 490.66M | 469.25M | 78.81M |
| Minority Interests | 99.98M | 114.77M | 19.34M | -270.45M | -287.21M | -1.92M |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
